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Introduction: Nanosized particles may enable therapeutic modulation of immune responses by 
targeting dendritic cell (DC) networks in accessible organs such as the lung. To date, however, 
the effects of nanoparticles on DC function and downstream immune responses remain poorly 
understood. 
Methods: Bone marrow–derived DCs (BMDCs) were exposed in vitro to 20 or 1,000 nm 
polystyrene (PS) particles. Particle uptake kinetics, cell surface marker expression, soluble 
protein antigen uptake and degradation, as well as in vitro CD4+ T-cell proliferation and 
cytokine production were analyzed by flow cytometry. In addition, co-localization of particles 
within the lysosomal compartment, lysosomal permeability, and endoplasmic reticulum stress 
were analyzed. 
Results: The frequency of PS particle–positive CD11c+/CD11b+ BMDCs reached an early 
plateau after 20 minutes and was significantly higher for 20 nm than for 1,000 nm PS particles 
at all time-points analyzed. PS particles did not alter cell viability or modify expression of the 
surface markers CD11b, CD11c, MHC class II, CD40, and CD86. Although particle exposure 
did not modulate antigen uptake, 20 nm PS particles decreased the capacity of BMDCs to 
degrade soluble antigen, without affecting their ability to induce antigen-specific CD4+ T-cell 
proliferation. Co-localization studies between PS particles and lysosomes using laser scanning 
confocal microscopy detected a significantly higher frequency of co-localized 20 nm particles as 
compared with their 1,000 nm counterparts. Neither size of PS particle caused lysosomal leakage, 
expression of endoplasmic reticulum stress gene markers, or changes in cytokines profiles. 
Conclusion: These data indicate that although supposedly inert PS nanoparticles did not induce 
DC activation or alteration in CD4+ T-cell stimulating capacity, 20 nm (but not 1,000 nm) PS 
particles may reduce antigen degradation through interference in the lysosomal compartment. 
These findings emphasize the importance of performing in-depth analysis of DC function when 
developing novel approaches for immune modulation with nanoparticles. 
Keywords: polystyrene particles, nanoparticles, immune modulation, mouse dendritic cells, 
CD4+ T-cells
Introduction
In recent years, intense research has focused on novel clinical applications for 
nanomaterials in medicine, including the potential use of engineered nanoparticles 
(NPs) as carriers for therapeutic applications.1 However, our knowledge regarding 
immune responses related to particulate exposure remains incomplete. Before nanocar-
riers may be considered for future medical applications, an in-depth understanding of 
NP–immune cell interactions is essential.2 Due to their nanoscale size, large surface 
area, surface reactivity, and chemical composition, NPs interact differently with 
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biological systems compared with larger-sized particles of the 
same material.3 Moreover, interactions of nanomaterials with 
the immune system are affected by physicochemical proper-
ties, such as size, surface coating, charge, or shape.4,5 Hence, 
potential nanocarriers require meticulous characterization 
to rule out any adverse toxicological and immunological 
responses prior to utilization in humans.6
Dendritic cells (DCs) are the most potent anti-
gen-presenting cells (APCs) in the respiratory tract and 
are specialized for capture, processing, and presentation 
of antigens.7,8 As key elements in regulating immunity 
and tolerance, DCs are essential for bridging innate and 
adaptive immune responses. Consequently, they are often 
targets for immunotherapeutic approaches. Furthermore, 
the respiratory tract represents an attractive target organ, 
given its enormous interface where interaction between 
DCs and novel inhalable nanocarrier-based vaccines may 
occur.9,10 DCs are heterogeneous and exist as multiple distinct 
subsets.11 Upon activation by antigen capture, cytokines, 
or lipopolysaccharides (LPS), immature DCs undergo a 
maturation process into so-called mature DCs.12 During this 
process, co-stimulatory molecules and maturation markers 
are upregulated, and mature DCs migrate towards regional 
lymph nodes where they may induce expansion of antigen-
specific CD4+ T-cells.13,14 Given the central importance of 
DCs in regulating immune responses, it is essential to gain 
knowledge about phenotypic and functional changes occur-
ring following exposure to different particle sizes and at 
different stages of DC maturation.
We recently reported that among intra-nasally instilled 
20, 50, 100, 200, and 1,000 nm polystyrene (PS) particles, 
particles with a diameter of 20 nm were most frequently 
captured by DCs compared with larger 1,000 nm particles, 
and only the smallest particles led to increased antigen-
specific CD4+ T-cell proliferation in local draining lymph 
nodes.15 For the present study, we utilized similar particles 
to further investigate basic mechanisms of particle–immune 
cell interactions and functional changes of DCs in vitro. We 
hypothesized that particle size is a key element in modula-
tion of DC function (ie, antigen uptake, degradation, and 
presentation). We employed fluorescent, negatively charged 
(carboxylated) PS particles of 20 and 1,000 nm in diameter. 
These widely employed, supposedly inert model particles 
were chosen as they are readily detected, available in different 
sizes with a narrow size distribution and were tested to be 
free of endotoxin contamination.15 We herein report our stud-
ies investigating the functional effects of 20 and 1,000 nm 
PS-particle exposure on mouse bone marrow–derived DCs 
(BMDCs), using in vitro differentiated immature and mature 
BMDCs to assess potential immune modulatory properties 
of PS particles. 
Materials and methods
Mice
Female BALB/c and DO11.10 TCR transgenic (BALB/c 
background) mice were bred specific pathogen free at the 
Department of Clinical Research (University of Berne, 
Switzerland) according to the Swiss Federal Veterinary 
Office guidelines under animal experimentation permission 
and used at 8–12 weeks of age. 
BMDc cultures, maturation, 
and exposure to Ps particles
DCs were generated from bone marrow as described 
elsewhere.16 This robust protocol provides a mixture of 
immature and mature DCs in the non-adherent cell fraction. 
For our experiments, we strictly employed non-adherent 
cells that are a mixture of DC precursors, immature DCs, 
and mature DCs. Briefly, BMDCs were generated by cul-
turing in Iscove’s Modified Dulbecco’s Medium (IMDM) 
(Invitrogen, Lucerne, Switzerland) containing 10% fetal calf 
serum (FCS), 1% L-glutamine, 1% penicillin/streptomycin, 
and 5% granulocyte-macrophage colony-stimulating factor 
(GM-CSF) (collected from culture supernatant of a X63-GM-
CSF myeloma cell line transfected with the murine GM-CSF 
gene) for 8 days at 37°C in a 5% CO
2
 humidified incubator. 
Five percent GM-CSF refers to 5% of the collected cell 
media, and titration of GM-CSF was initially performed 
before experiments with concentrations of 5%, 10%, and 15% 
GM-CSF. Five percent was then chosen, as it was the lowest 
concentration capable of inducing BMDC differentiation and 
activation following LPS incubation (data not shown). 
Yellow-green-labeled carboxylated PS particles of 20 nm 
(Molecular Probes, Lucerne, Switzerland) or 1,000 nm 
(Polysciences, Inc., Warrington, PA, USA) were employed. 
For cell viability experiments, BMDCs were exposed for 
16 hours to PS particles at a concentration ranging from 
25 µg/mL up to 100 µg/mL. For further experiments, 
concentrations for both PS-particle sizes were adjusted to 
25 µg/mL to rule out any cytotoxic effects. For NP-uptake 
experiments, BMDCs were first matured with 100 ng/mL 
LPS (Sigma-Aldrich, Buchs, Switzerland) for 16 hours 
(overnight), and PS particles were added the following day 
for different time-points (see below “Particle uptake studies 
using laser scanning microscopy”). For further experiments 
(antigen uptake, degradation and presentation experiments, 
co-localization with lysosomes, and endoplasmic reticulum 
[ER] stress), PS particles (25 µg/mL) and LPS (100 ng/mL) 
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were added concomitantly for 16 hours. All experiments were 
conducted with a cell concentration of 1×106 cells/mL.
Ps-particle characterization
PS particles were thoroughly characterized prior to use. The 
hydrodynamic size was measured by dynamic light scattering 
(DLS) (3DLS Spectrometer; LS Instruments AG,  Fribourg, 
Switzerland). Measurements were performed both in 
phosphate-buffered saline (PBS) and cell medium employed 
for experiments (IMDM +10% FCS). Zeta potential was 
determined in PBS using a Brookhaven-90 Plus Particle Size 
Analyzer (Brookhaven Instruments Corporation, Holtsville, 
NY, USA). Additionally, all particles were tested endotoxin 
free (according to the Limulus amebocyte lysate test; Lonza, 
Walkersville, MD, USA) as already described in a previous 
publication.15
Flow cytometry
Unless indicated otherwise, all antibodies were purchased 
from eBioscience (Vienna, Austria). All stainings were per-
formed strictly on ice as described.17 BMDC phenotype and 
activation state were assessed by staining with CD11b-APC-
Alexa Fluor 780, CD11c-APC, CD40-PE-Cy5, CD86-PE-
Cy7, and MHCII-PE. T-cells were stained with CD4-APC 
or CD4-APC-Alexa Fluor 780, CD3-biotin (secondary anti-
body: streptavidin-PE-Cy5), CD69-PE-Cy7, DO11.10 TCR 
(KJ-126)-PE, or DO11.10 TCR (KJ-126)-biotin (secondary 
antibody: streptavidin-FITC). Relevant isotype control anti-
bodies were employed as indicated. Propidium iodide (Invit-
rogen) and Annexin V-Alexa647 (BioLegend®, Lucerne, 
Switzerland) staining was performed to measure cell death 
and apoptosis, respectively. Samples were measured using 
a SORP LSRII (BD Biosciences, Franklin Lakes, NJ, USA), 
and the data obtained were analyzed using Flow Jo (Tree 
Star, Ashland, OR, USA) software.
Particle uptake studies using laser 
scanning microscopy (lsM)
BMDCs were matured for 16 hours with LPS, with LPS-
untreated BMDCs as controls. All cultures were incubated the 
following day with 20 or 1,000 nm PS particles (25 µg/mL) 
for a time course of 10, 20, 40, 60, and 90 minutes, and 2, 
4, 8, and 16 hours. After washing, BMDCs were spun down 
for 6 minutes at 900 rpm onto glass slides (Cytospin™ 
cytocentrifuge; Thermo Scientific, Zürich, Switzerland) and 
fixed in 70% alcohol for 5 minutes. Cells were permeabilized 
in 0.2% Triton X-100 (Sigma-Aldrich) and stained with 
phalloidin rhodamine (1:100; Molecular Probes) and with 
DAPI (4′,6-diamidino-2-phenylindole; 1 µg/mL; Invitro-
gen) for 1 hour at room temperature. Afterwards, the cells 
were washed and mounted in Aquatex mounting medium 
(Merck KGaA, Darmstadt, Germany). Optical sections were 
taken with a Zeiss LSM 710 (Carl Zeiss AG, Feldbach, 
Switzerland) with a 63× oil objective (Plan-Apochromat 
63×/1.40 Oil DIC M27) and a digital zoom of 3×. Image 
processing was performed using Imaris® (Bitplane AG, 
Zurich, Switzerland) software.
Measurement of antigen uptake 
and antigen degradation
Prior to antigen uptake, degradation, and presentation stud-
ies, ovalbumin (OVA) and bovine serum albumin (BSA) 
antigens were thoroughly titrated in preliminary experiments 
using a concentration series of 2.5, 10, 20, and 40 µg/mL for 
uptake and degradation and 5, 10, 20, 50, and 100 µg/mL 
for antigen presentation assays. In each case, the smallest 
concentration of antigen that induced robust CD4+ T-cell pro-
liferation was chosen (data not shown). Antigen uptake and 
degradation capacity of BMDCs were assessed as previously 
described.17,18 Briefly, cells were incubated with 2.5 µg/mL 
OVA-Alexa Fluor 647 (Molecular Probes) to assess uptake 
capacity or with 10 µg/mL BSA-DQ Red (Invitrogen) to 
determine degradation capacity. Cells were incubated for a 
time course of 0–60 minutes at 37°C or on ice (controls). 
Stimulation of carboxyfluorescein 
succinimidyl ester (cFse)-labeled 
OVA-specific T-cells
CD4+ T-cells from BALB/c DO11.10 mice were isolated 
using a CD4-positive isolation kit (Miltenyi Biotech, Bergisch 
 Gladbach, Germany). Cells were labeled with CFSE (eBiosci-
ence) and co-cultured for 72 hours with BMDCs that were pre-
viously incubated for 16 hours with LPS and/or PS particles, 
to a ratio 10:1 (T-cells/DCs). In addition, BMDCs were pulsed 
for 1 hour with 20 µg/mL OVA protein (Molecular Probes), or 
H-2d restricted OVA peptide (20 µg/mL, sequence 323–339; 
GenScript, Aachen, Germany) then added to the co-culture for 
72 hours. We employed the non-adherent BMDC cell popula-
tion without further cell sorting or purification steps. After the 
incubation period, antigen-specific T-cell proliferation (CFSE 
dilution) was measured by flow cytometry.
Intracellular cytokine staining 
DO11.10+/CD4+ T-cells and BMDCs were co-cultured 
as described in the section “Stimulation of carboxyfluo-
rescein succinimidyl ester (CFSE)-labeled OVA-specific 
T-cells” with or without 20 µg/mL OVA peptide (sequence 
323–339; GenScript) for 72 hours. On day 3, Brefeldin 
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A (20 µg/mL; eBioscience) was added to the cultures for 
2 hours. At the end of the culture period, cells were incu-
bated with antibodies against CD4 and the DO11.10 T-cell 
receptor (KJ-126) for 20 minutes on ice prior to fixation in 
1% formalin solution for 20 minutes. Cells were incubated 
in permeabilization buffer (PBS + 0.1% saponin +10% FCS) 
for 5 minutes at room temperature before the following 
anti-cytokine antibodies were added for 30 minutes: tumor 
necrosis factor (TNF)α-eF450, interferon (IFN)γ-eF450, 
interleukin (IL)10-PE, IL5-PE, IL17-PE-Cy7, and IL4-APC 
(all eBioscience). 
co-localization studies of Ps particles 
with lysosomes
For co-localization studies between lysosomes and PS 
particles, BMDCs were incubated in 8-well chamber slides 
(1µ-Slide ibiTreat microscopy chamber; ibidi GmbH, 
Martinsried, Germany) with 20 or 1,000 nm PS particles 
with or without concomitant LPS for 16 hours. Following 
PS-particle exposure, BMDCs were washed with IMDM, 
and the plasma membrane stained with CellMask™ 
Orange (6 µg/mL, Molecular Probes) and lysosomes with 
LysoTracker® Deep Red (1 µM, Molecular Probes) during 
1 hour at 37°C. The optimal amount of LysoTracker® Deep 
Red was titrated prior to co-localization studies and adjusted 
to 1 µM (data not shown). All micrographs were taken with 
a Zeiss LSM 710 (previously described). Micrographs used 
for three-dimensional reconstruction were taken with a 63× 
oil objective (previously described) and a digital zoom of 
3×, and image processing was performed using Imaris® 
software. Micrographs used to analyze co-localization 
were taken with a 40× oil objective (EC Plan-Neofluar 
40×/1.30 Oil DIC M27/a =0.21 mm) and image analysis 
was performed using ImageJ (NIH, Bethesda, Maryland, 
USA) software. The degree of co-localization was analyzed 
in single cells (cropped from LSM images) by assessing the 
Pearson coefficient. This is an intensity-based analysis where 
linear correlation between 2 channels (here lysosomes and 
PS particles) is measured, giving a value between +1 and −1, 
where 1 is total positive correlation, 0 is no correlation, 
and −1 is total negative correlation. Forty cells were ana-
lyzed for each condition. 
assessment of lysosome permeability
Lysosome permeability of BMDCs that were incubated for 
16 hours with LPS and/or PS particles was measured by flow 
cytometry using the dye acridine orange (AO; Molecular 
Probes). BMDCs were stained at 37°C with 5 µg/mL AO for 
15 minutes prior to flow cytometry analysis. 
er stress measurement
Total RNA was extracted from BMDCs treated with 
PS particles and/or LPS for 16 hours (NucleoSpin® 
RNA isolation kit; Macherey-Nagel, Oensingen, Swit-
zerland). Complementary DNA was synthesized from 
2 µg of RNA using the Omniscript™ RT kit (Qiagen, 
Hombrechtikon, Switzerland). Real-time polymerase 
chain reactions (PCR) were performed using specific 
primers for GRP78 (5′ AGCCCACCGTAACAAT-
CAAG and 5′ TCCAGCCATTCGATCTTTTC), CHOP 
(5′ CTGCCTTTCACCTTGGAGAC and 5′ CGTTTCCTG-
GGGATGAGATA), spliced XBP1 (5′ GAGTCCGCAG-
CAGGTGCAG and 5′ ACTGTGAGCGTCCAGCAGGC), 
IL-6 (5 ′  GGTGGACAACCACGGCCTTCCC and 
5′AAGCCTCCGACTTGTGAAGTGGT) and IL-1β 
(5′ AAAGCCTCGTGCTGTCGGACC and 5′ CAGGGTG-
GGTGTGCCGTCTT) (Microsynth, Balgach, Switzerland) 
and Fast SYBR Green Master Mix (Applied Biosystems®, 
Lucerne, Switzerland). Reactions were performed using a 
7500 Real-Time PCR System (Applied Biosystems®). Gene 
expression was normalized to 18S RNA (5′ CGCCGCTA-
GAGGTGAAATTCT and 5′ CATTCTTGGCAAAT-
GCTTTCG). Tunicamycin (2 µg/mL; Sigma-Aldrich) was 
used as positive control.19 
statistical analysis
All data are presented as mean ± SEM (standard error of the 
mean). Data were analyzed with ANOVA (one-way analy-
sis of variance) followed by Bonferroni post hoc test. Data 
were analyzed using GraphPad Prism® (La Jolla, CA, USA) 
software. Values were considered significantly different with 
P0.05 (*), P0.005 (**), or P0.001 (***). 
Results
Ps-particle characterization
Size of PS particles was measured with DLS in both PBS 
and cell medium containing 10% FCS. We observed a 
larger size of 20 nm PS particles than the dimensions pro-
vided by the manufacturer (31.3 nm in PBS, 43.9 nm in 
cell medium). When 20 nm PS particles were incubated in 
medium containing FCS, there was a modest increase in size 
compared with PBS, though this was still in the nanoscale. 
For 1,000 nm PS particles, results from DLS measurements 
confirmed the manufacturer specifications, both in PBS and 
cell medium (Table S1). Most importantly, for both particle 
sizes, DLS measurements and visual inspection excluded 
aggregation. Furthermore, samples were under observation 
for more than 3 days, during which period, stability was 
preserved. As previously published, the zeta potential for 
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20 nm PS particles was −15.4±1.4 mV, and for 1,000 nm PS 
particles, −17.5±1.9 mV.15
Ps particles do not induce apoptosis 
or cell death in BMDcs
Prior to testing the immunomodulatory effects of PS 
particles on BMDC functional activity, we screened both 
PS-particle sizes for potential cytotoxic effects. BMDCs 
were exposed for 16 hours (overnight) to 20 or 1,000 nm 
PS particles at concentrations ranging from 5 to 100 µg/mL 
with or without concomitant LPS. Levels of apoptotic and 
dead cells were assessed by flow cytometry using Annexin 
V and propidium iodide stainings, respectively. We did not 
observe an increase in apoptosis or cell death in BMDCs 
treated with either size of PS particle compared with the 
untreated group (Figure 1). Additionally, BMDC morphol-
ogy was unaltered by 25 µg/mL PS-particle or LPS treatment 
as demonstrated with light microscope pictures (Figure S1). 
For further experiments, a concentration of 25 µg/mL of 
PS particles was employed, as this concentration did not 
induce apparent cytotoxicity and has been shown in another 
study to be ideal in terms of fluorescence signal and cell 
viability.20
Ps-particle size determines internalization 
by BMDcs
To determine the uptake of both sizes of PS particles by 
BMDCs at different stages of maturation, immature or 
LPS-matured BMDCs were treated with 25 µg/mL 20 or 
1,000 nm PS particles during a time course of 10, 20, 40, 
60, and 90 minutes, and 2, 4, 8, and 16 hours. Cells were 
subsequently washed and labeled with antibodies to CD11c 
and CD11b and analyzed by flow cytometry. According to 
the literature, myeloid or conventional DCs that are in vitro 
derived from bone-marrow cells in the presence of  GM-CSF 
consistently show stable high expression of CD11c and 
CD11b.16,21 Frequencies of CD11c+/CD11b+ BMDCs con-
taining PS particles were then determined (Figure 2A). 
Our results showed significantly higher uptake of 20 nm 
compared with 1,000 nm PS particles in non-LPS-exposed 
BMDCs at all time-points studied (Figure 2B, left). Uptake 
of 20 nm PS particles reached a plateau after 20 minutes 
incubation, with approximately 75% of BMDCs positive 
for PS particles. In contrast, LPS-exposed BMDCs showed 
similar uptake for both particle sizes at early time-points, 
but at later time-points a significantly higher uptake of 
20 nm PS particles compared with 1,000 nm PS particles 
occurred (Figure 2B, right). We observed that uptake of 
20 nm PS particles by BMDCs remained stable during 
all time-points studied, irrespective of LPS exposure, 
whereas uptake of 1,000 nm PS particles at early time-
points (10–90 minutes) was significantly increased in 
LPS-exposed BMDCs compared with non-LPS-exposed 
BMDCs (Figure 2B).
To specifically determine whether PS particles were local-
ized intra- or extracellular, we performed an in-depth analysis 
of BMDCs by LSM (Figure 2C). As early as 10 minutes after 
PS-particle exposure, high numbers of 20 nm PS particles were 
detected inside BMDCs (Figure 2C [B and G]), compared with 
low numbers of 1,000 nm PS particles (Figure 2C [C and H]). 
In particular, lower magnification analyses provided evidence 
that although the majority of BMDCs contained 20 nm PS 
particles at early time-points, only a small number of BMDCs 
had taken up 1,000 nm PS particles (data not shown). More-
over, most 20 nm PS particles were localized intracellular, 
whereas a proportion of 1,000 nm PS particles were detected 
on the outer cell surface. Importantly, no PS particles were 
localized in cell nuclei at any time-point. 
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Figure 1 Assessment of BMDC viability using flow cytometry.
Notes: Frequencies of BMDcs in early apoptosis phase (left) or dead (right) following 16-hour incubation with 20 nm (gray) or 1,000 nm (black) Ps particles compared with 
non-treated cells (white), stained for Annexin V and PI, and measured by flow cytometry. Concentrations of PS particles ranged from 5 to 100 µg/ml. ann+ (positive control for 
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error of the mean.
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In summary, flow cytometry and LSM analyses 
demonstrated that both 20 and 1,000 nm PS particles were 
successfully taken up by BMDCs in a time-dependent man-
ner, although 20 nm PS particles were internalized more 
rapidly and to a greater extent compared with 1,000 nm PS 
particles. 
stable BMDc phenotype following 
treatment with Ps particles
We next aimed to analyze possible changes in BMDC 
phenotype and expression of co-stimulatory molecules 
following PS-particle exposure with or without concomitant 
LPS treatment. Employing flow cytometry with relevant 
isotype controls, we gated CD11c+/CD11b+ BMDCs to 
determine MHC class II+ (MHCII+), CD40+, and CD86+ 
cell frequencies (Figure 3A). The frequencies of CD40+ and 
CD86+ cells significantly increased upon LPS exposure, but 
were unaffected by PS-particle treatment of both sizes. In 
contrast, frequencies of MHCII+ cells remained unchanged 
by both LPS and/or PS-particle treatment (Figure 3B). Taken 
together, these findings suggest that neither 20 nor 1,000 nm 
PS particles induced alterations in BMDC surface phenotype 
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consecutive optical sections. Orange, actin; green, particles; blue, DaPI (nucleus). White bar: 10 µm. Magnification: 63× + 3× digital zoom. One representative experiment 
from four independent experiments is shown. 
Abbreviations: BMDc, bone marrow–derived dendritic cell; DaPI, 4′,6-diamidino-2-phenylindole; lPs, lipopolysaccharide; lsM, laser scanning microscopy; NP, nanoparticle; 
Ps, polystyrene; seM, standard error of the mean.
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and activation in the absence or presence of LPS-dependent 
maturation. 
size 20 nm Ps particles modulate 
antigen degradation in BMDcs
To investigate potential particle-mediated alterations of 
BMDC function, we investigated the capacity of BMDCs to 
take up and degrade antigen following PS-particle treatment. 
As previously reported, OVA coupled to Alexa647 and BSA 
coupled to DQ-Red were used to analyze antigen uptake and 
antigen degradation, respectively.18,22–24 The flow cytometry 
gating strategy from one representative experiment for OVA 
uptake and BSA degradation by CD11c+/CD11b+ BMDCs 
is shown in Figure 4A. In the absence of concomitant LPS 
exposure, OVA uptake was similar in CD11c+/CD11b+ 
BMDC cultures without particles compared with those incu-
bated with 20 or 1,000 nm PS particles. However, antigen 
uptake was reduced in LPS-treated BMDCs compared with 
 non-LPS-treated BMDCs, independently of PS-particle 
 exposure (Figure 4B, upper panels). Decreased antigen deg-
radation occurred in BMDCs treated with 20 nm PS particles 
but not with 1,000 nm PS particles, when compared with 
the untreated group, both in the presence or absence of LPS 
(Figure 4B, lower panels). Therefore, although PS particles did 
not alter antigen uptake by BMDCs, we observed decreased 
antigen degradation following exposure to 20 nm PS particles, 
both in immature (−LPS) and mature (+LPS) BMDCs. 
Antigen-specific T-cell stimulation 
by BMDcs remains stable following 
treatment with Ps particles 
We employed an in vitro OVA-specific DO11.10+/CD4+ 
T-cell proliferation assay to clarify whether alterations in 
antigen degradation induced by PS-particle treatment affect 
downstream antigen presentation and activation of CD4+ 
T-cells by BMDCs. Following treatment with PS particles 
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with or without LPS, BMDCs were co-cultured with CFSE-
labeled transgenic CD4+ T-cells specific for an H-2d-restricted 
OVA peptide. DO11.10+ (KJ-126+) CD4+ T-cells were gated 
(Figure 5A), and responses to OVA peptide and whole OVA 
protein were assessed by analyzing T-cell proliferation (CFSE 
dilutional profiles) after 72 hours of culture. The expansion 
index (EI) was measured based on CFSE profiles with the 
Flow Jo software. The EI is the ratio of final cell count to 
starting cell count and therefore represents the fold expan-
sion during culture.25 Independently of LPS, the EI remained 
unchanged for cells treated with PS particles as compared 
with untreated cells both for OVA peptide and OVA protein 
pulsed BMDCs (Figure 5B and C). Significant increases in 
CD4+ T-cell proliferation occurred in LPS-exposed BMDCs 
as compared with non-LPS-exposed cultures (Figure 5C). 
These data therefore suggest that antigen-specific T-cell 
stimulation by antigen-pulsed BMDCs, using either OVA 
peptide (antigen-degradation independent) and whole OVA 
protein (antigen-degradation dependent), remained unaf-
fected by PS-particle exposure of either size. 
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Ps particle–treated BMDcs  
do not alter antigen-specific  
cD4+ T-cell cytokine profiles
Although PS-particle exposure did not alter BMDC antigen 
presentation and CD4+ T-cell proliferation, we next deter-
mined whether immune responses may be affected by altera-
tion of T-cell cytokine profiles. To test this, DO11.10+/CD4+ 
T-cells were co-cultured with PS particle–exposed BMDCs 
(±LPS) for 72 hours in the presence or absence of 20 µg/mL 
OVA peptide. Production of the cytokines IFN-γ and TNF-α 
(Th-1), IL-4 and IL-5 (Th-2), IL-17 (Th-17), IL-10 (regula-
tory T-cells)26 by CD4+ T-cells was assessed by intracellular 
staining and flow cytometry (Figure 6). OVA peptide ±LPS, 
but not LPS alone, induced cytokine production that was not 
affected by PS-particle treatment of BMDCs. 
size 20 nm Ps particles co-localize with 
lysosomes without increasing lysosome 
permeability
To understand why antigen degradation was decreased 
following treatment with 20 nm PS particles but not with 
larger 1,000 nm PS particles, we analyzed the extent to which 
PS particles co-localized with lysosomes, as these organelles 
are the site where antigen degradation takes place. Following 
16 hours incubation with 25 µg/mL PS particles, lysosomes 
were stained using the lysosomal marker LysoTracker® Deep 
Red, which labels acidic organelles,3,27–29 and examined by 
confocal microscopy. While almost all 20 nm PS particles 
co-localized with lysosomes, fewer 1,000 nm PS particles 
 co-localized in lysosomes (Figure 7A, arrows). We next quanti-
fied co-localization using the Pearson coefficient. A  significant 
increase in co-localization with lysosomes occurred following 
incubation with 20 nm compared with 1,000 nm PS particles in 
both untreated and LPS-treated BMDCs (Figure 7B). In addi-
tion, co-localization of 20 nm PS particles in LPS-treated 
BMDCs was higher than in non-treated BMDCs (Figure 7B). 
To exclude that PS-particle fluorescence changes occurred at 
acidic pH in lysosomes, potentially influencing particle detec-
tion, we investigated the emission fluorescence intensity of 
PS particles in buffer solutions at pH 5 and pH 7 at different 
time-points. No significant differences in fluorescence inten-
sity occurred at pH 5 and pH 7 for both 20 and 1,000 nm PS 
particles at all time-points (Figure S2).
We further assessed whether PS particles could affect 
lysosomal membrane integrity and therefore induce leakage 
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of lysosomal enzymes into the cytosol, by using the dye AO. 
AO accumulates in lysosomes and leads to red fluorescence, 
which decreases when the dye leaks out of the lysosomes into 
the cytosol due to increased permeability. AO-negative gating 
was used to assess the percentage of AOlow BMDCs, which rep-
resents cells with lower AO fluorescence intensity, thus perme-
able lysosomes (Figure 7C). We observed that incubation with 
25 µg/mL of both 20 and 1,000 nm PS particles did not increase 
permeability of lysosomes (Figure 7D), providing evidence that 
lysosomes remain intact at the concentrations utilized. 
Ps particles do not induce 
er stress in BMDcs
One stage in antigen degradation involves synthesis of MHC 
class II molecules in the ER. Following synthesis, MCHII 
molecules are transported to endosomal vesicles, where 
they are loaded with antigen-derived peptides.30 To identify 
potential adverse effects of PS particles on this phase of 
antigen processing, we assessed ER stress in BMDCs which 
were previously incubated with 25 µg/mL PS particles. 
The ER stress response is triggered when an accumulation of 
misfolded or unfolded proteins is found in the lumen of the 
ER under stress conditions.31,32 Expression of different ER 
stress gene markers such as GRP78 chaperone and adaptive 
pathways CHOP and spliced XBP1 were measured by real-
time-PCR. Expression of the pro-inflammatory cytokines 
IL-1β and IL-6 was also determined. Tunicamycin, a known 
ER stress inducer, was employed as positive control for ER 
stress. Treatment of BMDCs with PS particles did not trigger 
an increased expression of messenger RNA (mRNA) encod-
ing GRP78, CHOP and spliced XBP1, or transcription of the 
genes encoding the cytokines IL-1β and IL-6 (Figure 8). Treat-
ment of cells with LPS induced, as expected, an expression of 
IL-1β mRNA; this was, however, unchanged in the presence 
of PS particles. These results indicate that PS particles did not 
induce an apparent ER stress response in BMDCs. 
Discussion
Despite recent intensive research in the field of nanomedicine, 
fundamental knowledge about nanomaterial–cell interactions 
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is still insufficient, particularly in understanding effects 
on the immune system. It has been recognized to date that 
NP–cell interactions are affected by a number of diverse 
particle properties, such as size, shape, and surface charge. 
In this study, we aimed to analyze size-dependent effects on 
BMDCs during treatment with nanosized (20 nm) and micro-
sized (1,000 nm) PS particles in an in vitro model. The scope 
of the present study was to focus on particle size in order 
to systematically and thoroughly analyze size-dependent 
effects, and therefore only PS particles were included in the 
present study. Further evaluations are in progress employing 
a recently established fluorescence-encoded gold-NP library 
with different surface modifications33 in order to understand 
surface-dependent effects. The underlying study is comple-
mentary to our recent work showing that in vivo lung DC 
subpopulations preferentially capture and traffic 20 nm 
PS particles compared with 1,000 nm PS particles, where 
smaller particles induce enhanced CD4+ T-cell proliferation 
in draining lymph nodes.15 In the current study, we provided 
an exhaustive investigation into particle-dependent modula-
tion of DC function and showed that treatment with particles 
did not affect cell viability, surface phenotype (CD11c and 
CD11b), or activation (CD40, CD86, and MHCII) markers. 
Although particle treatment did not modulate antigen uptake, 
20 nm PS particles decreased the capacity of BMDCs to 
degrade antigen irrespective of LPS exposure, compared with 
larger 1,000 nm PS particles that did not modulate BMDC 
function. For both PS-particle sizes, BMDC-mediated 
antigen-specific stimulation of CD4+ T-cells and induction 
of cytokines remained similar to non-particle-exposed con-
trol cells. Furthermore, we observed that co-localization of 
20 nm PS particles with lysosomes was significantly higher 
compared with 1,000 nm PS particles, without measurable 
perturbation of lysosomal function or ER stress. 
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We adopted a widely employed robust model utilizing 
submersed cultures of BMDCs to allow straightforward 
administration of PS particles and analyses by flow cyto-
metry and confocal microscopy. Nevertheless, it is central 
to interpret the data in the context of the particle  application 
method employed in this study (as described in the Meth-
ods section): for every particle size, a suspension contain-
ing 25 µg/mL of PS particles was administrated; hence, 
there is a 125,000-fold difference in particle numbers at 
the extremes between 20 and 1,000 nm PS particles. This 
difference in particle number could theoretically influence 
particle uptake by BMDCs measured by determining fluo-
rescence intensities. This potential bias in particle numbers 
is countered by limitations in detection sensitivity by 
flow cytometry: While fluorescence emitted from a single 
1,000 nm PS particle is highly above detection threshold 
and can therefore easily be detected by flow cytometry, 
this is not the case for single 20 nm PS particles (data not 
shown). Therefore, with our approach that heavily relied 
on detecting and tracing sufficiently fluorescent particles 
over a wide size range, utilizing equal particle mass was 
the most appropriate strategy to account for size-dependent 
variations in fluorescence intensities.15 The resolution of 
microscopy is limited to approximately 200 nm in lateral 
and 500 nm in axial dimension.34 Although single 20 nm 
PS particles cannot be distinguished, the number of pixels 
GRP78
IL-6 IL-1β
CHOP Spliced XBP1
G
R
P7
8/
18
s 
ra
tio
C
H
O
P/
18
s 
ra
tio
Sp
lic
ed
 X
PB
1/
18
s
ra
tio
IL
6/
18
s 
ra
tio
IL
1β
/1
8s
 ra
tio
10 25
20
10
8
6
4
2
0
15
10
5
0
8
6
4
2
0
10 15
10
5
0
8
6
4
2
0
–LPS +LPS TM –LPS +LPS TM –LPS +LPS TM
–LPS +LPS TM
No NP
20 nm
1,000 nm
–LPS +LPS TM
***
**
Figure 8 Messenger rNa expression level of different markers for endoplasmic reticulum stress measured by real-time-Pcr in BMDcs following Ps-particle exposure.
Notes: expression of GRP78, CHOP, and XBP1, as well as pro-inflammatory cytokines IL1-β and Il-6 were assessed in cells left untreated (white) or incubated overnight 
with 25 µg/ml 20 nm (gray) or 1,000 nm (black) Ps particles. expression levels of genes of interest were normalized to 18s gene expression. all ratios were normalized to the 
ratio of No NP −lPs (BMDcs unexposed to Ps particles and untreated with lPs). red bars show expression level for TM, a positive control for endoplasmic reticulum stress. 
Bar graphs show mean ± seM; **P0.005, ***P0.001 (TM versus no NP −lPs); n=4. 
Abbreviations: BMDc, bone marrow–derived dendritic cell; lPs, lipopolysaccharide; NP, nanoparticle; Pcr, polymerase chain reaction; Ps, polystyrene; TM, tunicamycin; 
seM, standard error of the mean; Il, interleukin.
generating a signal event can be quantified. As previously 
reported, we employed this approach to analyze both 
20 and 1,000 nm PS particles15 or fluorescent-magnetic 
hybrid NPs.34
In line with our findings, a previous study by Frick 
et al35 showed that human DCs incubated with negatively 
charged phosphonated and sulfonated PS particles of an aver-
age diameter of 245 and 227 nm, respectively, at concentra-
tions of 25, 75, and 150 µg/mL for 24 hours does not cause 
significant apoptosis. Another study by Zupke et al20 deter-
mined that only larger PS particles (100 and 500 nm) at a 
concentration of 50 µg/mL for 24, 48, and 72 hours induced 
significant cytotoxicity in NIH 3T3 fibroblast cells compared 
with smaller PS particles (50 nm). In fact, even though PS 
particles employed in our study are often considered to be 
chemically inert and safe, it is essential to realize that such 
particles may induce biological effects partly associated 
with surface charge.36 It is indeed often reported that posi-
tively charged PS particles trigger cell death even at low 
concentrations when compared with neutral or negatively 
charged particles, indicating that the surface coating plays a 
major role in cell death induced by particles.3,37,38 Since we 
employed negatively charged PS particles for our exposures, 
the low levels of cell death found following PS-particle 
treatment can be explained by the negative surface charge 
of our PS particles. 
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We also provided evidence for a differential uptake 
of 20 and 1,000 nm PS particles by immature (non-LPS-
exposed) BMDCs. In immature BMDCs, uptake of 20 nm 
PS particles reached an early plateau after 20 minutes, 
whereas this only occurred after 60 minutes for 1,000 nm 
PS particles. The frequency of particle-positive BMDCs 
was always lower for 1,000 nm than for 20 nm PS particles. 
Employing cell lines, a human in vitro study with negatively 
charged PS particles ranging from 40 nm to 2 µm showed that 
uptake was also size-dependent for all cell lines tested.39 As 
expected, it was also demonstrated that phagocytic cells 
have a much higher internalization capacity compared with 
other cell types, although all NPs tested still could enter 
all cell lines.39 Moreover, when monitoring size-dependent 
uptake, Johnston et al40 reported limited uptake of 200 nm 
compared with 20 nm PS particles in human hepatocytes. In 
line with our study, a study by Foged et al41 also confirmed 
that optimal particle diameter for rapid uptake by human 
immature DCs is below 50 nm. Pathways by which NPs 
enter cells are to date still not fully understood and depend 
on cell type, size, surface charge, shape, and bulk material 
of NPs used.39,42,43 Rejman et al44 found that internalization 
of particles smaller than 200 nm involves clathrin-mediated 
endocytosis, while with increasing particle size caveolae-
mediated internalization occurs. Another study showed 
that larger PS particles (200 nm) are found on the cell 
surface,40 suggesting that larger particles could be bound to 
receptors on the plasma membrane prior to internalization. 
Moreover, in another study from our group, we employed 
the J774A.1 mouse macrophage cell line to compare uptake 
of 1,000 nm and 40 nm PS particles using different inhibi-
tors of endocytotic pathways (Kuhn et al, unpublished data, 
2014). We found that 40 nm PS particles undergo clathrin-
mediated uptake and macropinocytosis or phagocytosis, 
while 1,000 nm PS particles are taken up only by macropi-
nocytosis or phagocytosis. 
A salient finding in the present study is that uptake of 
20 nm PS particles by BMDCs was unchanged following 
LPS exposure, whereas uptake of 1,000 nm PS particles 
was increased in LPS-exposed BMDCs. These results are 
contrary to our general understanding that immature DCs 
are endowed with ability for antigen uptake but with a poor 
capacity to present antigen to naïve T-cells. In response 
to antigen encounter or danger signals such as LPS, DCs 
undergo maturation and are capable to prime naïve T-cells 
while shutting down their ability for antigen uptake.12,45 A 
potential explanation for increased uptake of larger particles 
may be that immature BMDCs, upon activation by LPS, 
increase the number of dendrites and therefore their surface 
area. Larger PS particles may therefore more readily adhere 
and be taken up by BMDCs. These findings should, however, 
be further investigated. It was noteworthy, however, that 
although PS-particle uptake was not affected by LPS stimula-
tion, our data confirmed that LPS exposure and maturation 
of BMDCs decreased their capacity for uptake of soluble 
antigen (OVA). 
DCs are key players in induction of immune responses, 
and their function is closely influenced by their level of so-
called maturation. Maturation of DCs is known to be medi-
ated by different danger signals such as microbial products 
and results in upregulated expression of co-stimulatory 
molecules.46 To assess effects of PS-particle incubation on 
BMDCs, we analyzed BMDC maturation and phenotype 
after PS-particle treatment. Our data showed that PS-particle 
treatment did not induce or alter maturation of BMDCs, as 
frequencies of cells expressing MHC Class II, CD40, and 
CD86 remained unaffected. Findings reported in the literature 
regarding capacity of PS particles to induce maturation of 
immune cells also show that with similar conditions (con-
centration and incubation time), no significant difference 
in expression levels of activation markers occurs following 
incubation with PS particles.20,35 
Another aspect of DC immune function is the capacity 
of antigen uptake and antigen degradation. While uptake of 
labeled OVA protein was not altered by the presence of 
PS particles, degradation of antigen was downregulated 
in BMDCs treated with 20 nm PS particles, but not with 
1,000 nm PS-particle treatment. The model antigen OVA 
employed in antigen-uptake experiments was endotoxin-free 
and not modified by the addition of carbohydrate moieties; 
therefore, as myeloid C-type lectin receptors (CLR) 
on immune cells such as DCs recognize carbohydrate 
moieties on antigen,47 it is unlikely that CLR-binding of 
OVA-Alexa647 accounts for the extent of antigen uptake 
observed. These new findings confirm that particle size may 
represent a relevant parameter determining DC function, as 
only BMDCs treated with nanosized particles were unable 
to fully degrade or process OVA antigen. Interestingly, the 
capacity of particle-treated BMDCs to stimulate CD4+ T-cells 
remained stable when compared with untreated BMDCs, 
indicating that decreased antigen degradation did not affect 
induction of T-cell proliferation. Indeed, although antigen 
degradation capacity was significantly decreased in the pres-
ent study, it was not completely shut down. We suggest that 
the reduced level of antigen degradation was still sufficient to 
induce measurable antigen-specific CD4+ T-cell proliferation. 
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Other in vitro studies using PS particles show divergent find-
ings concerning their immune-modulatory potential.20,35 In 
a recent in vivo study, we showed that negatively charged 
20 nm PS particles are able to enhance antigen presentation 
to CD4+ T-cells in lung-draining lymph nodes.15 Also, another 
study in vivo demonstrated that glycine-coated PS particles of 
50 nm markedly dampen the ability of CD11b+ DCs in lung-
draining lymph nodes to stimulate OVA-specific T-cells.48 
In addition to antigen uptake, antigen degradation and 
T-cell stimulatory capacity, cytokine production in CD4+ 
T-cells co-cultured with particle-exposed BMDCs was 
assessed. Our study showed no influence of PS particles on 
expression of all cytokines tested, suggesting that particle-
exposed BMDCs did not alter the T helper (Th) cell cytokine 
profiles. Results reported in the literature are discordant on 
particle-dependent effects on Th profiles. For instance, a 
Th-1 shift with increased IFN-γ production was measured 
in human immature DCs treated with 75 µg/mL positively 
charged PS particles,35 while an in vivo study showed that 
PS particles do not induce an increase in BAL fluid IFN-γ 
or IL-17 but prevented Th-2 immunity.48 Johrden et al49 also 
demonstrated that production of IFN-γ by CD4+ and CD8+ 
T-cells is not increased following incubation with PS 
particles. These findings further reveal that comparability 
between studies is often limited. Indeed, many parameters 
may have been an influence when investigating NP potential 
to modulate immune cells: size, coating, and surface charge 
of the administered NPs, but also responder T-cell types 
utilized, concentration of particles, endotoxin contamination, 
or incubation time. 
In search of an explanation for reduced antigen degrada-
tion in BMDCs following exposure to 20 nm PS particles, we 
detected increased co-localization with lysosomes compared 
with 1,000 nm PS particles, but without causing measurable 
changes in lysosomal permeability. Recent studies indicate 
that NP toxicity is associated with oxidative stress and 
inflammation, but underlying mechanisms are not known 
in detail.50–52 Among other potential mechanisms, lyso-
somal dysfunction and impairment of autophagy have been 
described to be a consequence of NP–cell interactions.53 There 
are different possible ways by which NPs can induce these 
alterations. It was first shown by several studies that since 
NPs are sequestered in lysosomes they could accumulate in 
those compartments and induce lysosomal dysfunction by 
inducing membrane permeability or defects in lysosomal 
trafficking.27,29,54 We could show that particles were mainly 
localized in vesicles, including lysosomes, but not in other cel-
lular compartments such as mitochondria or the cell nucleus. 
By applying a quantitative analysis by stereology on transmis-
sion electron microscopy, which has a much higher resolu-
tion, we showed that the preferred particle localization is in 
vesicles.55 Also, it was proposed by Monick et al56 that lyso-
somal overload by particles induces blockade of autophagy 
flux in alveolar macrophages from smokers, resulting in mito-
chondrial dysfunction and cytotoxicity. Moreover, overload-
ing lysosomes with indigestible nanomaterials such as gold, 
was shown to block autophagosome–lysosome fusion and 
lysosomal degradation.28 This finding may therefore indicate 
that supposedly inert, yet biopersistent nanomaterials such 
as PS may not cause direct toxicity or cellular effects, but 
may be of greater concern, as they accumulate in lysosomes 
where they are not degraded properly and might block other 
key cellular functions in DC such as antigen degradation. 
To further understand possible causes for impaired 
antigen degradation capacity, we thoroughly investigated 
potential size-dependent induction of ER stress and expres-
sion of pro-inflammatory cytokines by measuring respective 
mRNA levels of ER stress gene markers GRP78, CHOP, and 
spliced XBP1 and the pro-inflammatory markers IL-1β and 
IL-6. Neither particle size was found to induce ER stress or 
expression of pro-inflammatory cytokine mRNA. As a major 
indicator of ER stress, GRP78 (78 kDa glucose-regulated 
protein, also called BiP) is an ER chaperone protein hold-
ing stress-sensing proteins in an inactivate state in normal 
conditions.57 Upon ER stress, IRE1, a transmembrane protein, 
mediates the removal and thus splicing of an intron from 
XBP1 (x-box binding protein 1) mRNA. This spliced form 
of XBP1 is then an effective transcription factor that trans-
locates to the nucleus for transcription of various genes such 
as GRP78. As previously reported, in humans, XBP1 is also 
required for the transcription of MHCII genes.58,59 CHOP (C/
EBP homologous protein, also called DNA damage-inducible 
transcript 3) is involved in ER stress–related apoptosis and is 
upregulated when there is unsuccessful cell recovery. It has 
been reported in different studies that the three markers for 
ER stress response we measured are reliable for the detection 
of ER stress and that these are upregulated following incuba-
tion with silver and poly(lactic-co-glycolic acid) NPs.31,60 We 
are not aware of any study investigating ER stress during 
PS-particle exposure. Therefore, we here report for the first 
time data suggesting that PS particles of either size did not 
induce ER stress response, inflammation, and apoptosis, 
contrary to other NP types. 
To our knowledge, the underlying study provided initial 
evidence in the field that nanosized particles accumulate in 
lysosomes, affecting key lysosomal functions such as antigen 
International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3899
Particle size modulates dendritic cell function
degradation. Moreover, we also showed that these effects were 
size-dependent, as only NPs (20 nm) but not microparticles 
(1,000 nm) of the same material caused impaired antigen 
degradation. Therefore, particle size is a relevant para-
meter determining DC function and may critically influence 
downstream immune responses. Although other BMDC 
functions such as antigen uptake or antigen-specific CD4+ 
T-cell stimulation remained unaffected, these data highlight 
the complexity of cellular interactions with supposedly inert, 
yet biopersistent, nanomaterials causing functional alterations 
in key immune cells such as DCs through congestion of the 
lysosomal compartment. It is tempting to speculate that a 
larger amount of 20 nm PS particles with a relatively greater 
surface area might lead to increased absorption of proteolytic 
enzymes in lysosomes – further investigations will be neces-
sary to understand the mechanisms involved. These findings 
have important implications for the future design of novel 
therapeutic nanocarriers that may require either an enhanced or 
dampened immune response to unfold their clinical effects.
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Supplementary materials
Table S1 size measurement of 20 nm and 1,000 nm polystyrene particles employing Dls
Size 
(given by manufacturer)
Diameter/σ 
measured by DLS 
PBS
Diameter/σ 
measured by DLS 
IMDM +10% FCS
20 nm 31.3 nm/58.2% 43.9 nm/66.4%
1,000 nm 941.2 nm/19.6% 944.9/19.7%
Notes: Measurements were performed in PBs and cell medium (IMDM +10% FCS). To account for polydispersity, the intensity-weighted statistical average was normalized by 
particle volume distribution, approximating a number-weighted statistical average of spherical nanoparticles. The diameter represents arithmetic average, and the dispersion 
in size is quantified by σ (polydispersity index = sD/average). The onset of aggregation can be excluded, proved by Dls and visual inspection. Furthermore, the samples were 
under observation for more than 3 days, during which time the initial stability was preserved.
Abbreviations: DLS, dynamic light scattering; FCS, fetal calf serum; IMDM, Iscove’s Modified Dulbecco’s Medium; PBS, phosphate-buffered saline; SD, standard deviation.
Figure S1 assessment of BMDc viability using light microscopy.
Notes: Images show that BMDc morphology was not altered by 25 µg/ml Ps-particle and lPs treatment. Black bar: 100 µm. Magnification: 20×.
Abbreviations: BMDc, bone marrow–derived dendritic cell; lPs, lipopolysaccharide; NP, nanoparticle; Ps, polystyrene.
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Figure S2 Assessment of emission fluorescence intensity of PS particles in buffer solutions at pH 5 and pH 7 after 10 minutes, 1 hour, 4 hours, and 16 hours incubation.
Notes: Measurements were performed to determine stability of PS-particle fluorescence under physiologic and acidic pH conditions. PS particles were diluted at a 
concentration of 25 µg/ml in 0.1 M acetate buffer solution at ph 5 and 0.1 M phosphate buffer at ph 7. Fluorescence intensities were determined at the respective excitation 
and emission wavelengths specific for each PS particle and given by the manufacturer (20 nm, 505/515 nm; 1000 nm, 441/486 nm). Results are expressed as Δ Intensity = 
measured sample fluorescence intensity minus measured blank (phosphate-buffered saline) fluorescence intensity. Measurements were performed on an Infinite M1000 
PrO (Tecan, Männedorf, switzerland). Three independent experiments were performed (n=3); for each experiment, five measurements with identical parameters were 
averaged.
Abbreviation: Ps, polystyrene.
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